grace capital purchased a new stake in shares of CVS Health Corp (NYSE:CVS) during the second quarter, HoldingsChannel reports. The fund purchased 7,500 shares of the pharmacy operator’s stock, valued at approximately $483,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Camarda Financial Advisors LLC bought a new position in CVS Health in the 2nd quarter valued at about $102,000. Quantbot Technologies LP bought a new position in CVS Health in the 1st quarter valued at about $103,000. Kiley Juergens Wealth Management LLC bought a new position in CVS Health in the 2nd quarter valued at about $103,000. Legacy Advisors LLC lifted its position in CVS Health by 7,100.0% in the 2nd quarter. Legacy Advisors LLC now owns 1,800 shares of the pharmacy operator’s stock valued at $116,000 after acquiring an additional 1,775 shares in the last quarter. Finally, Squar Milner Financial Services LLC bought a new position in CVS Health in the 2nd quarter valued at about $122,000. 83.57% of the stock is currently owned by institutional investors and hedge funds.

NYSE:CVS opened at $76.91 on Friday. The company has a quick ratio of 1.87, a current ratio of 2.34 and a debt-to-equity ratio of 1.73. The stock has a market capitalization of $78.72 billion, a price-to-earnings ratio of 11.73, a PEG ratio of 1.04 and a beta of 1.01. CVS Health Corp has a 52 week low of $60.14 and a 52 week high of $84.00.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, August 8th. The pharmacy operator reported $1.69 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.61 by $0.08. The firm had revenue of $46.71 billion during the quarter, compared to analyst estimates of $46.34 billion. CVS Health had a net margin of 1.61% and a return on equity of 18.25%. The company’s revenue for the quarter was up 2.2% on a year-over-year basis. During the same quarter last year, the business posted $1.33 EPS. equities analysts forecast that CVS Health Corp will post 7.05 earnings per share for the current year.

In other CVS Health news, EVP Kevin Hourican sold 8,564 shares of the stock in a transaction dated Monday, August 27th. The shares were sold at an average price of $75.00, for a total value of $642,300.00. Following the completion of the sale, the executive vice president now owns 12,135 shares in the company, valued at approximately $910,125. The transaction was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 0.53% of the company’s stock.

CVS has been the topic of several recent research reports. Mizuho set a $95.00 price target on shares of CVS Health and gave the company a “buy” rating in a research report on Wednesday, June 13th. Royal Bank of Canada dropped their price target on shares of CVS Health to $84.00 and set an “outperform” rating on the stock in a research report on Friday, June 29th. Morgan Stanley dropped their price target on shares of CVS Health from $88.00 to $80.00 and set an “overweight” rating on the stock in a research report on Tuesday, July 3rd. Citigroup reaffirmed a “buy” rating and issued a $81.00 price target on shares of CVS Health in a research report on Monday, July 9th. Finally, Leerink Swann set a $80.00 price target on shares of CVS Health and gave the company an “outperform” rating in a research report on Thursday, August 9th. Two research analysts have rated the stock with a sell rating, four have given a hold rating, eleven have given a buy rating and two have issued a strong buy rating to the company. CVS Health presently has an average rating of “Buy” and an average target price of $86.04.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Further Reading: NASDAQ Stock Market Explained

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.